Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan
- 14 March 2008
- journal article
- retracted article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 102 (5), 597-606
- https://doi.org/10.1161/circresaha.107.165464
Abstract
RETRACTION This article has been retracted: Circ Res. 2018;123:e00. DOI: 10.1161/RES.0000000000000244 Heart failure is the leading cause of death in the elderly, but whether this is the result of a primary aging myopathy dictated by depletion of the cardiac progenitor cell (CPC) pool is unknown. Similarly, whether current lifespan reflects the ineluctable genetic clock or heart failure interferes with the genetically determined fate of the organ and organism is an important question. We have identified that chronological age leads to telomeric shortening in CPCs, which by necessity generate a differentiated progeny that rapidly acquires the senescent phenotype conditioning organ aging. CPC aging is mediated by attenuation of the insulin-like growth factor-1/insulin-like growth factor-1 receptor and hepatocyte growth factor/c-Met systems, which do not counteract any longer the CPC renin–angiotensin system, resulting in cellular senescence, growth arrest, and apoptosis. However, pulse-chase 5-bromodeoxyuridine–labeling assay revealed that the senescent heart contains functionally competent CPCs that have the properties of stem cells. This subset of telomerase-competent CPCs have long telomeres and, following activation, migrate to the regions of damage, where they generate a population of young cardiomyocytes, reversing partly the aging myopathy. The senescent heart phenotype and heart failure are corrected to some extent, leading to prolongation of maximum lifespan.Keywords
This publication has 29 references indexed in Scilit:
- Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdUNature, 2007
- Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart FailureCirculation, 2007
- Stem cell niches in the adult mouse heartProceedings of the National Academy of Sciences of the United States of America, 2006
- Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarctionProceedings of the National Academy of Sciences of the United States of America, 2006
- Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombinationAmerican Journal of Physiology-Renal Physiology, 2005
- Average remaining lifetimes can increase as human populations ageNature, 2005
- The Plasticity of Aging: Insights from Long-Lived MutantsCell, 2005
- Manipulation of stem cell proliferation and lineage commitment:visualisation of label-retaining cells in wholemounts of mouse epidermisDevelopment, 2003
- Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell, 2003
- IGF-1 receptor regulates lifespan and resistance to oxidative stress in miceNature, 2002